["{\"step_by_step_thinking\": \"The patient is a 71-year-old man with urinary hesitancy and nocturia of increasing frequency over the past several months. The digital rectal exam was positive for a slightly enlarged prostate but did not detect any additional abnormalities of the prostate or rectum. The serum PSA was measured to be 6 ng/mL. This suggests that the patient may have benign prostatic hyperplasia (BPH). The transabdominal ultrasound image A shows no additional abnormalities.\n\nThe medication options provided are: Clonidine, Finasteride, Dihydrotestosterone, and Furosemide.\n\nFinasteride is a 5-alpha-reductase inhibitor that has been shown to be effective in treating BPH. It works by reducing the production of dihydrotestosterone (DHT), a hormone that contributes to the growth of the prostate gland.\n\nClonidine is an alpha-adrenergic agonist that can help reduce symptoms of BPH such as urinary frequency and noturia, but it is not specifically indicated for treating BPH.\n\nFurosemide is a diuretic that may be used to treat patients with underlying heart failure or kidney disease, but it is not directly related to the patient's condition.\n\nDihydrotestosterone is a hormone that can contribute to the growth of the prostate gland and is not a medication that would be used to treat BPH.\n\nTherefore, Finasteride should be included in the treatment plan for the patient.\", \"answer_choice\": \"B\"}"]